BioSpace News Archive

Business

Announcing Gerry Zack as the new CEO of the Society of Corporate Compliance and Ethics & Health Care Compliance Association

The Society of Corporate Compliance and Ethics & Health Care Compliance Association (SCCE & HCCA) are pleased to announce that Gerry Zack is the new CEO as of November 1, 2018.

November 1, 2018
·
2 min read
BioCapital

November is National Bladder Health Awareness Month

Get the Facts, Get Diagnosed and Take Control of Your Bladder Health

November 1, 2018
·
4 min read
Biotech Beach

The Journal of Urology Publishes Valencia’s Excellent Feasibility Data on eCoin™ for Overactive Bladder

Last week, The Journal of Urology published the feasibility data of Valencia Technologies’ (“Valencia”) eCoin™ device indicated for treatment of overactive bladder.

November 1, 2018
·
2 min read
Business

Food Allergy Research & Education Debuts “In a Matter of Minutes,” New PSA with Steve Carell

New Video Raises Awareness of Food Allergy as Serious Public Health Disease

November 1, 2018
·
2 min read
Business

Cardiac Insight, Inc. Partners with VivoSense® (Vivonoetics, Inc.) to Expand the Use of Its Wearable Cardiac Sensors in Regulated Pharmaceutical Clinical Trials and Other Healthcare Research Applications

Partnership to Provide Advanced Insights Into Performance of New Medicines and Therapies

November 1, 2018
·
4 min read
BioCapital

GlycoMimetics to Present Analyses from Phase 1/2 AML Trial of Uproleselan at 60th ASH Meeting

New and updated clinical outcomes data and subgroup analyses continue to demonstrate potential benefit of treatment with uproleselan when added to chemotherapy

November 1, 2018
·
11 min read
BioMidwest

Rebiotix, C. Diff Foundation Commend State of Minnesota for Declaring November Clostridium difficile Awareness Month

Proclamation heightens public awareness and impact of the devastating infection.

November 1, 2018
·
4 min read
Pharm Country

Fast Growing Medical Device Company, SIG Medical, Closes Seed Round

SIG Medical pioneers a minimally-invasive procedure, AdvantageRib, to revolutionize treatment of painful rib fractures.

November 1, 2018
·
2 min read
Business

XTL Biopharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Update

TL Biopharmaceuticals Ltd. announced financial results for the quarter ended September 30, 2018 and provided an update on the development program for its lead drug candidate hCDR1.

November 1, 2018
·
6 min read
Policy

Vertex Announces European Authorization for Third Cystic Fibrosis Medicine SYMKEVI® (tezacaftor/ivacaftor), to be used in combination with ivacaftor (KALYDECO®), for People with CF Aged 12 and Older with Certain Mutations in the CFTR gene

A new treatment option for patients with two copies of the F508del mutation, the most common mutation in cystic fibrosis

November 1, 2018
·
6 min read